Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

27.29
Delayed Data
As of May 27
 +0.41 / +1.53%
Today’s Change
23.85
Today|||52-Week Range
43.63
-36.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues113.7M148.2M130.9M115.9M
 
 
 
 
 
Cost of Goods Sold19.1M21.2M22.7M19.4M
 
 
 
 
 
Depreciation And Amortization3.8M3.7M3.9M3.9M
 
 
 
 
 
 
Operating ExpensesGross Income90.8M123.3M104.3M92.6M
 
 
 
 
 
General Expenses84.0M94.4M97.0M96.4M
 
 
 
 
 
Research And Development31.2M43.4M44.0M44.6M
 
 
 
 
 
Total Operating Expenses106.9M119.3M123.5M119.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.8M28.9M7.4M-3.8M
 
 
 
 
 
Extraordinary Credit--0.000.0010.3M
 
 
Extraordinary Charge-1.1M-3.2M-3.5M-13.4M
 
 
 
 
 
Interest Expense On Debt4.0M4.0M3.4M3.7M
 
 
 
 
 
Other Expenses351.0K-59.0K0.00142.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.1M21.7M655.0K-10.3M
 
 
 
 
 
Income Taxes-1.1M-17.8M-8.6M-9.7M
 
 
 
 
 
Net Income997.0K3.9M9.2M-520.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.1M42.2M42.6M44.8M
 
 
 
 
 
Shares To Calculate EPS Diluted43.3M43.4M44.2M44.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.02$0.09$0.21-$0.01
 
 
 
 
 
EPS Diluted$0.02$0.09$0.21-$0.01